Enhanced hepatic delivery of siRNA and microRNA using oleic acid based lipid nanoparticle formulations-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Enhanced hepatic delivery of siRNA and microRNA using oleic acid based lipid nanoparticle formulations

Published:2013-12 Issue:3 Volume:172 Page:690-698
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Wang Xinmei,Yu Bo,Ren Wei,Mo Xiaokui,Zhou Chenguang,He Hongyan,Jia HuLiang,Wang Lu,Jacob Samson T.,Lee Robert J.,Ghoshal Kalpana,Lee L. James

Funder

NSF Nanoscale Science and Engineering Center (NSEC)

NIH

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference45 articles.

1. Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles;Davis;Nature,2010

2. First-in-humans trial of an RNA interference therapeutic targeting VEGF and KSP in cancer patients with liver involvement;Tabernero;Cancer Discov.,2013

3. Confirming the RNAi-mediated mechanism of action of siRNA-based cancer therapeutics in mice;Judge;J. Clin. Invest.,2009

4. The Gordon Wilson Lecture. The ABC's of viral hepatitis;Krugman;Trans. Am. Clin. Climatol. Assoc.,1992

5. Altered mental status in cirrhosis: etiologies and outcomes;Rahimi;J. Investig. Med.,2013

Cited by 83 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lipid Nanoparticles as a Platform for miRNA and siRNA Delivery in Hepatocellular Carcinoma;Current Drug Delivery;2024-05-02

2. Preparation and Optimization of MiR-375 Nano-Vector Using Two Novel Chitosan-Coated Nano-Structured Lipid Carriers as Gene Therapy for Hepatocellular Carcinoma;Pharmaceutics;2024-04-03

3. Vaccine adjuvants for infectious disease in the clinic;Bioengineering & Translational Medicine;2024-03-22

4. Lipoamino bundle LNPs for efficient mRNA transfection of dendritic cells and macrophages show high spleen selectivity;European Journal of Pharmaceutics and Biopharmaceutics;2024-01

5. Lipid nanoparticles as the drug carrier for targeted therapy of hepatic disorders;Journal of Materials Chemistry B;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3